Improving access, innovation, reach key to achieving UHC
Putting Universal Healthcare (UHC) at the top of the agenda, OPPI’s recent conclave on ‘Improving Access, Innovation and Reach of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Trends Exports organises seminar on EU-GMP inspection
Trends Exports recently organised a seminar in Mumbai for understanding regulatory aspects of EU-GMP inspection in Europe.
Russia’s pharma market: So near, and yet so far
Indian pharma companies have preserved in the Russian pharma market, in spite of the many entry barriers. But Union Minister Anand…
EU Commission proposes revamp of clinical trial rules
Faced with a decrease of 25 per cent in the number of clinical trials conducted in teh EU between 2007 and 2011, the EU Commission…
DuBiotech and IDMA to promote two-way investment between UAE and India
Companies operating in Dubai Biotechnology & Research Park are keen to invest in the Indian market. Likewise Indian…
FDA raids cause chemists to return MTP kits, contraceptives
Confusion over state FDA order leads to knee jerk reaction from chemists
DNDi and Cipla to develop antiretroviral drug combination
New formulation to provide appropriate HIV medicines for infants and young children
Taro’s Special Committee rejects proposal from Sun Pharma
Offer deemed "inadequate, not in the best interests of Taro’s minority shareholders"
Domestic pharma companies likely to see steady growth in Q1 FY13: Analysts
Tax rates hikes and forex losses could however cloud the picture for certain companies
Zydus Urosciences launches Udenafil
The inhibitor has been launched for the first time in India to cure erectile dysfunction
Canada-India Business Council signs MoU with Gujarat govt
To focus on sectors like pharmaceuticals, telecom, energy and finance
Novartis Q2 result enhances future growth prospects
Achieves eight significant regulatory milestones in the same quarter
Integrated Cure
Though allopathy and alternative medicine have their own strengths and limitations, an integrated approach brings the best of both…
Serum Institute of India buys Bilthoven Biologicals
Serum Institute of India, the flagship company of Poonawalla Group and India’s largest vaccine company, has acquired Bilthoven…
”We intend to build the HiOwna brand into a Rs 100-crore business”
Recently, the Himalaya Drug Company launched 'HiOwna-Jr' flagging its entry into the nutraceutical and dietary supplement market.…
SC hearing of Novartis patent case re-scheduled for August 22
Postponement due to a request from lawyers representing Novartis
AIOCD to support market-based pricing formula based on all-brands
Likely to address patient needs and balance industry growth